158 related articles for article (PubMed ID: 18220535)
1. Radiosensitization of prostate cancer by soy isoflavones.
Raffoul JJ; Sarkar FH; Hillman GG
Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
4. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
Hillman GG
Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones sensitize cancer cells to radiotherapy.
Hillman GG; Singh-Gupta V
Free Radic Biol Med; 2011 Jul; 51(2):289-98. PubMed ID: 21605661
[TBL] [Abstract][Full Text] [Related]
6. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
Hillman GG; Singh-Gupta V; Hoogstra DJ; Abernathy L; Rakowski J; Yunker CK; Rothstein SE; Sarkar FH; Gadgeel S; Konski AA; Lonardo F; Joiner MC
Radiother Oncol; 2013 Oct; 109(1):117-25. PubMed ID: 24021346
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
[TBL] [Abstract][Full Text] [Related]
12. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
13. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury.
Hillman GG; Singh-Gupta V; Runyan L; Yunker CK; Rakowski JT; Sarkar FH; Miller S; Gadgeel SM; Sethi S; Joiner MC; Konski AA
Radiother Oncol; 2011 Nov; 101(2):329-36. PubMed ID: 22079530
[TBL] [Abstract][Full Text] [Related]
16. Emerging evidence on the role of soy in reducing prostate cancer risk.
Messina MJ
Nutr Rev; 2003 Apr; 61(4):117-31. PubMed ID: 12795445
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effect of cisplatin in prostate cancer cell lines.
Geldof AA; Slotman BJ
Cancer Lett; 1996 Mar; 101(2):233-9. PubMed ID: 8620475
[TBL] [Abstract][Full Text] [Related]
18. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
19. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
